Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
Background/Objectives: Visceral adipose tissue (VAT) may play a direct role in the development of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH). In this study, we employed untargeted proteomics analyses...
Saved in:
| Main Authors: | Julie S. Pedersen, Lili Niu, Nicolai J. Wewer Albrechtsen, Viggo B. Kristiansen, Inge Marie Poulsen, Reza R. Serizawa, Torben Hansen, Lise Lotte Gluud, Sten Madsbad, Flemming Bendtsen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Livers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-4389/5/2/16 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials
by: Hazem Ayesh, et al.
Published: (2024-10-01) -
Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom
by: Elizabeta Knezović, et al.
Published: (2025-02-01) -
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
by: Ankita Dua, et al.
Published: (2025-08-01) -
AI‐Based Platelet‐Independent Noninvasive Test for Liver Fibrosis in MASLD Patients
by: Shun‐ichi Wakabayashi, et al.
Published: (2025-04-01) -
C/EBPβ–VCAM1 axis in Kupffer cells promotes hepatic inflammation in MASLD
by: Shuang-Zhe Lin, et al.
Published: (2025-08-01)